Validated 1-Year Mortality Prediction in Patients with Three-Vessel Disease Undergoing Contemporary PCI: Insights from the Multivessel TALENT trial

Eur Heart J Qual Care Clin Outcomes. 2026 Jul 28:qcag122. doi: 10.1093/ehjqcco/qcag122. Online ahead of print.ABSTRACTBACKGROUND: Accurate risk stratification for patients with three-vessel coronary artery disease (3VD) undergoing percutaneous coronary intervention (PCI) remains important in contemp

A Asahi Oshima

Sex differences in microvascular patterns associated with low- and high-risk for cardiovascular disease

Biol Sex Differ. 2026 Jul 27;17(1):138. doi: 10.1186/s13293-026-00955-0.ABSTRACTBACKGROUND: The role of the microcirculation in cardiovascular health in males and females is not fully understood. Skin microvascular function can be assessed non-invasively by measuring the response to a brief occlusio

E Elin Nyman

Pulse Doppler ultrasound measurement of central artery elasticity: an exploratory study

Cardiovasc Ultrasound. 2026 Jul 23;24(1):24. doi: 10.1186/s12947-026-00385-3.ABSTRACTBACKGROUND: Arterial stiffness, as a biomarker of cardiovascular diseases, is most often described by a surrogate global stiffness index, pulse pressure wave velocity (PWV), a measure of the time for pressure pulses

T Trevor Tucker

Late complications after autologous HSCT for autoimmune diseases: a retrospective survey from the autoimmune diseases working party (ADWP), transplant complications working party (TCWP) and paediatric diseases working party (PDWP) of the european society for blood and marrow transplantation (EBMT)

Bone Marrow Transplant. 2026 Jul 27. doi: 10.1038/s41409-026-02983-1. Online ahead of print.ABSTRACTAutologous hematopoietic stem cell transplantation (aHSCT) has evolved as a treatment for severe autoimmune diseases (ADs). Advances in transplant procedures and supportive care have led to improvemen

K Kirill Kirgizov

USP15-mediated deubiquitination of FIS1 impairs mitochondrial function and sensitizes bladder cancer cells to radiotherapy

Oncogene. 2026 Jul 27. doi: 10.1038/s41388-026-03918-2. Online ahead of print.ABSTRACTWhile radiation therapy plays a pivotal role in the treatment of advanced invasive bladder cancer, its efficacy is often limited when used as alone, underscoring the need to identify molecular targets that regulate

R Ruxin Xiong

SERCA2 gatekeeper role in aortic autophagy: targeting the Ca2+-mTOR axis to prevent aortic dissection

Acta Pharmacol Sin. 2026 Jul 27. doi: 10.1038/s41401-026-01887-6. Online ahead of print.ABSTRACTAortic dissection (AD) is a catastrophic cardiovascular syndrome with an in-hospital mortality of more than 90%. We previously identified oxidative inactivation of sarcoplasmic/endoplasmic reticulum Ca2+-

L Lang-Tao Wang

A PET reporter ligand for quantitative imaging of gene expression in the brain

Nat Biomed Eng. 2026 Jul 27. doi: 10.1038/s41551-026-01748-x. Online ahead of print.ABSTRACTThe lack of brain penetrant and biologically stable positron emission tomography reporter systems hampers the development of neurological disease models and the monitoring of gene delivery because existing ap

S Sophie Stotz

Association of the cardiometabolic index and depressive symptoms with cardiovascular disease in cardiovascular-kidney-metabolic syndrome stages 0-3: A prospective cohort study

Sci Rep. 2026 Jul 24;16(1):23340. doi: 10.1038/s41598-026-63006-z.ABSTRACTThe progressive nature of cardiovascular-kidney-metabolic syndrome (CKM) allows early intervention during stages 0-3. However, the role of the cardiometabolic index (CMI) across CKM stages 0-3 and its potential synergy with de

Y Yuehua Li

Smooth muscle cell spheroids as 3D model of phenotypic plasticity and matrix deposition revealed by 2D-3D proteomics

Sci Rep. 2026 Jul 27;16(1):23357. doi: 10.1038/s41598-026-61834-7.ABSTRACTVascular smooth muscle cells (VSMCs) are regulators of vascular homeostasis and play a role in cardiovascular diseases, including atherosclerosis and aortic aneurysms. Together with endothelial cells (ECs), they control vascul

J Julia Hesse

Cardioprotective properties of empagliflozin and other SGLT2 inhibitors

Nat Rev Cardiol. 2026 Jul 27. doi: 10.1038/s41569-026-01325-4. Online ahead of print.ABSTRACTSince the publication of the landmark EMPA-REG OUTCOME trial, sodium-glucose cotransporter 2 (SGLT2) inhibitors have redefined the therapeutic landscape of cardiovascular-kidney-metabolic disease. Initially

T Thomas A Zelniker

Innovations in glaucoma treatment: development and testing of a novel self-adjustable implant for effective pressure regulation

Microsyst Nanoeng. 2026 Jul 27;12(1):280. doi: 10.1038/s41378-026-01400-3.ABSTRACTGlaucoma drainage devices (GDDs) are widely used to lower intraocular pressure (IOP) and slow disease progression; however, existing designs often lack intrinsic protection against early postoperative hypotony, show li

S Soroush Rafiei

Burden and epidemiology of inguinal, femoral, and abdominal hernias in the Middle East and North Africa region from 1990 to 2023

Surgery. 2026 Jun 5:110380. doi: 10.1016/j.surg.2026.110380. Online ahead of print.ABSTRACTBACKGROUND: There are limited studies on the burden of hernia in the Middle East and North Africa region. This study aimed to assess the burden of inguinal, femoral, and abdominal hernias by utilizing data fro

A Abdolhossein Hajizadeh

Associations between non-high-density lipoprotein cholesterol levels and renal pathological changes in a population with apparently normal kidney function

J Clin Lipidol. 2026 Jul 10:S1933-2874(26)00441-1. doi: 10.1016/j.jacl.2026.07.013. Online ahead of print.ABSTRACTBACKGROUND: Dyslipidemia has been identified as a crucial factor for atherosclerotic disease. Recently, evidence for involvement of non-high-density lipoprotein cholesterol (nHDL-C) in a

E Eri Ataka

Lipoprotein(a) and atrial fibrillation: Meta-analysis of observational and mendelian randomization studies shows no clinically meaningful association

J Clin Lipidol. 2026 Jul 10:S1933-2874(26)00439-3. doi: 10.1016/j.jacl.2026.07.006. Online ahead of print.ABSTRACTBACKGROUND: Elevated lipoprotein(a) [Lp(a)] is an established risk factor for atherosclerotic cardiovascular disease, but its relationship with atrial fibrillation (AF) remains uncertain

M Md Fahim

Accuracy of Large Language Models in Extracting Literature Features for Cardiovascular Disease Exercise Rehabilitation Nursing: A Diagnostic Study

Heart Lung Circ. 2026 Jul 27:S1443-9506(26)00479-8. doi: 10.1016/j.hlc.2026.05.032. Online ahead of print.ABSTRACTBACKGROUND & AIM: Accurate extraction of clinical and methodological features from published literature is essential for supporting evidence-based cardiovascular rehabilitation. With the

X Xinglin Zheng

Dynamic prediction of cardiovascular risk from linked primary care records in New South Wales, Australia: protocol for a retrospective prognostic modelling study

BMJ Open. 2026 Jul 27;16(7):e122980. doi: 10.1136/bmjopen-2026-122980.ABSTRACTINTRODUCTION: Cardiovascular disease (CVD) remains a leading cause of preventable morbidity and mortality. Most existing CVD prediction tools use a baseline survival modelling framework, in which each predictor is represen

N Nicholas I-Hsien Kuo

Zwitterionic peptide-grafted S-CNQDs/Cu2O photocathode for reliable photoelectrochemical detection of cardiac troponin I

Anal Chim Acta. 2026 Oct 1;1417:345773. doi: 10.1016/j.aca.2026.345773. Epub 2026 Jun 1.ABSTRACTBACKGROUND: Reliable detection of cardiac troponin I (cTnI) in complex biological fluids is essential for early diagnosis of cardiovascular diseases. However, biofouling from nonspecific protein adsorptio

Z Zhiyue Cai

Fast untargeted and targeted high-resolution mass spectrometry workflows for large-scale lipidomics

Anal Chim Acta. 2026 Oct 1;1417:345759. doi: 10.1016/j.aca.2026.345759. Epub 2026 Jun 2.ABSTRACTBACKGROUND: Lipidomes are highly complex and variable, and high-throughput analytical strategies are essential for comprehensive lipidome profiling in large-scale analysis. The use of hydrophilic interact

Y Yi Yun Pang

Menopausal Considerations in Transgender and Gender-Diverse Individuals

Obstet Gynecol Clin North Am. 2026 Sep;53(3):591-602. doi: 10.1016/j.ogc.2026.04.005. Epub 2026 May 13.ABSTRACTAssessing and treating menopause in transgender and gender diverse (TGD) individuals is of increasing interest to clinicians providing gender-affirming care. There currently exists a small

N Neha Reddy

Midlife Sleep and Circadian Health: Implications for Cardiovascular and Cognitive Outcomes

Obstet Gynecol Clin North Am. 2026 Sep;53(3):483-495. doi: 10.1016/j.ogc.2026.03.006. Epub 2026 May 13.ABSTRACTMidlife women, particularly during the menopausal transition, experience heightened vulnerability to sleep and circadian health disturbances. These disruptions are driven by hormonal change

L Leslie M Swanson

Myocardial Bridging Independently Associates With Coronary Artery Spasm

No abstractJACC Cardiovasc Interv. 2026 Jul 27;19(14):1959-1962. doi: 10.1016/j.jcin.2026.03.026. Epub 2026 May 11.NO ABSTRACTPMID:42508854 | DOI:10.1016/j.jcin.2026.03.026

R Robert Sykes

Impact of Aortic Annulus Size on Outcomes After Aortic Valve Replacement: The PARTNER 3 Trial

JACC Cardiovasc Interv. 2026 Jul 27;19(14):1944-1955. doi: 10.1016/j.jcin.2026.05.023.ABSTRACTBACKGROUND: There are limited studies comparing the impact of transcatheter aortic valve replacement (TAVR) vs surgical aortic valve replacement (SAVR) by annular size.OBJECTIVES: The aim of this post hoc a

M Mahesh V Madhavan

Trends and Outcomes of Antithrombotic Strategies for Valve-in-Valve TAVR: The STS/ACC TVT Registry

JACC Cardiovasc Interv. 2026 Jul 27;19(14):1927-1939. doi: 10.1016/j.jcin.2026.05.026.ABSTRACTBACKGROUND: The optimal antithrombotic strategy after valve-in-valve (ViV) transcatheter aortic valve replacement (TAVR) for degenerated aortic bioprostheses remains undetermined, and current practice patte

H Hiroki A Ueyama

Timing of Bleeding and Ischemic Events in High-Bleeding Risk Patients Treated With 1-Month DAPT

JACC Cardiovasc Interv. 2026 Jul 27;19(14):1910-1922. doi: 10.1016/j.jcin.2026.05.027.ABSTRACTBACKGROUND: Understanding the concomitant evolution of bleeding vs ischemic risk after percutaneous coronary intervention (PCI) in patients at high bleeding risk (HBR) treated with 1-month dual antiplatelet

G Guillaume Marquis-Gravel